| Picard Medical, Inc. (PMI) | |||||||||||||||||||||||||||||||||||||||||||||||||
| Q3-CY2026 | Q2-CY2026 | Q1-CY2026 | Q4-CY2025 | Q3-CY2025 | Q2-CY2025 | Q1-CY2025 | Q4-CY2024 | Q3-CY2024 | Q2-CY2024 | Q1-CY2024 | Q4-CY2023 | Q3-CY2023 | Q2-CY2023 | Q1-CY2023 | Q4-CY2022 | Q3-CY2022 | Q2-CY2022 | Q1-CY2022 | Q4-CY2021 | Q3-CY2021 | Q2-CY2021 | Q1-CY2021 | Q4-CY2020 | Q3-CY2020 | Q2-CY2020 | Q1-CY2020 | Q4-CY2019 | Q3-CY2019 | Q2-CY2019 | Q1-CY2019 | Q4-CY2018 | Q3-CY2018 | Q2-CY2018 | Q1-CY2018 | Q4-CY2017 | Q3-CY2017 | Q2-CY2017 | Q1-CY2017 | Q4-CY2016 | Q3-CY2016 | Q2-CY2016 | Q1-CY2016 | Q4-CY2015 | Q3-CY2015 | Q2-CY2015 | Q1-CY2015 | Q4-CY2014 | Q3-CY2014 | |
| Balance Sheet Date | 2026-Jun-30 | 2026-Mar-31 | 2025-Dec-31 | 2025-Sep-30 | 2025-Jun-30 | ||||||||||||||||||||||||||||||||||||||||||||
| Fiscal Period | Q2-FY2026 | Q1-FY2026 | Q4-FY2025 | Q3-FY2025 | Q2-FY2025 | ||||||||||||||||||||||||||||||||||||||||||||
| Operating Cash Flow | (1,352,000$) | (3,800,000$) | (4,377,000$) | (6,514,000$) | (2,241,000$) | (3,152,000$) | (2,608,000$) | ||||||||||||||||||||||||||||||||||||||||||
| Investing Cash Flow | 0$ | (26,000$) | |||||||||||||||||||||||||||||||||||||||||||||||
| Purchases of Property and Equipment | 0$ | 26,000$ | |||||||||||||||||||||||||||||||||||||||||||||||
| Financing Cash Flow | 1,246,000$ | (7,522,000$) | 13,017,000$ | 8,949,000$ | 2,834,000$ | 3,233,000$ | 2,528,000$ | ||||||||||||||||||||||||||||||||||||||||||
| End Cash Position | 38,000$ | 121,000$ | 7,451,000$ | 2,813,000$ | 410,000$ | 96,000$ | 78,000$ | ||||||||||||||||||||||||||||||||||||||||||
| Exchange Rate Effect | 23,000$ | 18,000$ | (2,000$) | (15,000$) | (1,000$) | 9,000$ | |||||||||||||||||||||||||||||||||||||||||||
| Dividends Paid | |||||||||||||||||||||||||||||||||||||||||||||||||
| Unlevered Free Cash Flow | (1,352,000$) | (3,826,000$) | (4,377,000$) | (6,514,000$) | (2,241,000$) | (3,152,000$) | (2,608,000$) | ||||||||||||||||||||||||||||||||||||||||||